Beauregard G, Roufogalis B D
Biochem J. 1979 Apr 1;179(1):109-17. doi: 10.1042/bj1790109.
Acetylcholinesterase was released from bovine erythrocytes in hypo-osmotic sodium phosphate buffer. Initially, about 30% of the enzyme was released in a soluble lipoprotein form, and further incubation resulted in the progressive release of the enzyme in a particulate form. Solubilization of the acetylcholinesterase in the particulate fraction with Lubrol WX (2 mg/ml) resulted in the loss of all lipids except a non-exchangeable fraction identified as cardiolipin. Addition of a mixture of erythrocyte phospholipids to the soluble forms and to the Lubrol WX-solubilized enzyme resulted in the formation of particulate forms of the enzyme with increased partial specific volume and Stokes radius, and a break in the Arrhenius plot of the enzyme activity around 20 degrees C. The break in the Arrhenius plot was abolished by treatment of a soluble enzyme preparation with 1.8 M salt (NaCl) in phosphate buffer, conditions that allowed the extraction of cardiolipin from the enzyme by chloroform/methanol. Failure of the high-salt treatment to decrease the Stokes radius made it unlikely that the bound cardiolipin formed a boundary layer or annulus around the protein. It is suggested that cardiolipin is bound to the core of the dimeric protein structure, thereby controlling the acetylcholinesterase activity.
乙酰胆碱酯酶在低渗磷酸钠缓冲液中从牛红细胞中释放出来。最初,约30%的酶以可溶性脂蛋白形式释放,进一步孵育导致酶以颗粒形式逐渐释放。用Lubrol WX(2 mg/ml)使颗粒部分中的乙酰胆碱酯酶溶解,结果除了一种被鉴定为心磷脂的不可交换部分外,所有脂质都丢失了。向可溶性形式和Lubrol WX溶解的酶中添加红细胞磷脂混合物,导致形成颗粒形式的酶,其偏比容和斯托克斯半径增加,并且酶活性的阿伦尼乌斯图在20℃左右出现断点。通过在磷酸盐缓冲液中用1.8 M盐(NaCl)处理可溶性酶制剂,阿伦尼乌斯图中的断点被消除,这种条件允许用氯仿/甲醇从酶中提取心磷脂。高盐处理未能减小斯托克斯半径,这使得结合的心磷脂不太可能在蛋白质周围形成边界层或环。有人提出,心磷脂与二聚体蛋白质结构的核心结合,从而控制乙酰胆碱酯酶的活性。